HealthEquity ROA 2014-2025 | HQY
Current and historical return on assets (ROA) values for HealthEquity (HQY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| HealthEquity ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-07-31 | $0.15B | $3.42B | 4.24% |
| 2025-04-30 | $0.12B | $3.42B | 3.52% |
| 2025-01-31 | $0.10B | $3.45B | 2.83% |
| 2024-10-31 | $0.10B | $3.49B | 2.89% |
| 2024-07-31 | $0.11B | $3.51B | 3.26% |
| 2024-04-30 | $0.08B | $3.25B | 2.58% |
| 2024-01-31 | $0.06B | $3.16B | 1.81% |
| 2023-10-31 | $0.03B | $3.09B | 0.98% |
| 2023-07-31 | $0.01B | $3.07B | 0.42% |
| 2023-04-30 | $-0.01B | $3.04B | -0.29% |
| 2023-01-31 | $-0.03B | $3.09B | -0.88% |
| 2022-10-31 | $-0.06B | $3.07B | -1.95% |
| 2022-07-31 | $-0.06B | $3.07B | -2.04% |
| 2022-04-30 | $-0.06B | $3.07B | -1.80% |
| 2022-01-31 | $-0.05B | $3.11B | -1.44% |
| 2021-10-31 | $-0.01B | $3.10B | -0.23% |
| 2021-07-31 | $0.00B | $3.15B | 0.00% |
| 2021-04-30 | $0.00B | $3.16B | 0.14% |
| 2021-01-31 | $0.01B | $2.71B | 0.34% |
| 2020-10-31 | $0.00B | $2.66B | 0.15% |
| 2020-07-31 | $-0.02B | $2.66B | -0.73% |
| 2020-04-30 | $0.00B | $2.56B | 0.00% |
| 2020-01-31 | $0.04B | $2.57B | 2.35% |
| 2019-10-31 | $0.05B | $2.56B | 4.45% |
| 2019-07-31 | $0.09B | $1.10B | 13.42% |
| 2019-04-30 | $0.09B | $0.60B | 18.43% |
| 2019-01-31 | $0.08B | $0.51B | 16.12% |
| 2018-10-31 | $0.07B | $0.48B | 15.81% |
| 2018-07-31 | $0.06B | $0.46B | 15.52% |
| 2018-04-30 | $0.06B | $0.42B | 15.20% |
| 2018-01-31 | $0.05B | $0.37B | 13.83% |
| 2017-10-31 | $0.05B | $0.36B | 14.18% |
| 2017-07-31 | $0.04B | $0.33B | 13.93% |
| 2017-04-30 | $0.03B | $0.30B | 11.67% |
| 2017-01-31 | $0.03B | $0.28B | 10.14% |
| 2016-10-31 | $0.03B | $0.26B | 10.34% |
| 2016-07-31 | $0.02B | $0.25B | 10.05% |
| 2016-04-30 | $0.02B | $0.23B | 8.77% |
| 2016-01-31 | $0.02B | $0.22B | 8.00% |
| 2015-10-31 | $0.02B | $0.21B | 9.20% |
| 2015-07-31 | $0.02B | $0.20B | 9.41% |
| 2015-04-30 | $0.01B | $0.17B | 10.31% |
| 2015-01-31 | $0.01B | $0.16B | 13.76% |
| 2014-07-31 | $0.01B | $0.07B | 42.42% |
| 2014-04-30 | $0.01B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.074B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.291B | 27.23 |
| HCA Healthcare (HCA) | United States | $108.759B | 18.01 |
| CVS Health (CVS) | United States | $100.272B | 11.53 |
| Elevance Health (ELV) | United States | $70.623B | 10.36 |
| Cencora (COR) | United States | $69.932B | 22.56 |
| Natera (NTRA) | United States | $27.391B | 0.00 |
| DiDi Global (DIDIY) | China | $25.980B | 21.23 |
| Labcorp Holdings (LH) | United States | $20.950B | 15.98 |
| Medpace Holdings (MEDP) | United States | $16.595B | 41.20 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| ICON (ICLR) | Ireland | $12.852B | 12.75 |
| Solventum (SOLV) | United States | $12.405B | 12.04 |
| CochLear (CHEOY) | Australia | $12.093B | 0.00 |
| Viatris (VTRS) | United States | $11.656B | 4.34 |
| Revvity (RVTY) | United States | $10.292B | 18.95 |
| Charles River Laboratories (CRL) | United States | $8.271B | 15.93 |
| Avantor (AVTR) | United States | $7.875B | 12.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.226B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.746B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.977B | 35.63 |
| Bausch + Lomb (BLCO) | Canada | $5.508B | 36.16 |
| Sotera Health (SHC) | United States | $4.455B | 21.48 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $4.039B | 70.93 |
| Alignment Healthcare (ALHC) | United States | $3.268B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.757B | 34.68 |
| Concentras Parent (CON) | United States | $2.479B | 15.47 |
| Premier (PINC) | United States | $2.324B | 22.52 |
| Ardent Health (ARDT) | United States | $2.061B | 7.96 |
| Progyny (PGNY) | United States | $1.923B | 37.92 |
| Pediatrix Medical (MD) | United States | $1.883B | 11.25 |
| Establishment Labs Holdings (ESTA) | $1.883B | 0.00 | |
| PACS (PACS) | United States | $1.878B | 0.00 |
| Organon (OGN) | United States | $1.763B | 1.92 |
| Teladoc Health (TDOC) | United States | $1.336B | 0.00 |
| Omada Health (OMDA) | $1.169B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.081B | 17.28 |
| Embecta (EMBC) | United States | $0.807B | 4.72 |
| CareDx (CDNA) | United States | $0.803B | 13.13 |
| InnovAge Holding (INNV) | United States | $0.718B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.685B | 9.45 |
| Nutex Health (NUTX) | United States | $0.637B | 9.64 |
| Sonida Senior Living (SNDA) | United States | $0.604B | 0.00 |
| Pomdoctor - (POM) | China | $0.540B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.523B | 0.00 |
| So-Young (SY) | China | $0.449B | 0.00 |
| CryoPort (CYRX) | United States | $0.420B | 0.00 |
| Enhabit (EHAB) | United States | $0.402B | 18.07 |
| Auna S.A (AUNA) | Luxembourg | $0.401B | 6.02 |
| Charming Medical (MCTA) | $0.374B | 0.00 | |
| Strata Critical Medical (SRTA) | United States | $0.362B | 0.00 |
| KindlyMD (NAKA) | United States | $0.339B | 0.00 |
| Oncology Institute (TOI) | United States | $0.331B | 0.00 |
| SBC Medicals (SBC) | United States | $0.327B | 7.16 |
| Agilon Health (AGL) | United States | $0.277B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.225B | 0.00 |
| Beauty Health (SKIN) | United States | $0.178B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.124B | 0.00 |
| DocGo (DCGO) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.095B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.89 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |